These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1283 related items for PubMed ID: 24242678

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
    Chen X, Wang X, Ruan A, Han W, Zhao Y, Lu X, Xiao P, Shi H, Wang R, Chen L, Chen S, Du Q, Yang H, Zhang X.
    Clin Cancer Res; 2014 May 15; 20(10):2617-30. PubMed ID: 24647573
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
    Ma X, Fan Y, Gao Y, Zhang Y, Huang Q, Ai Q, Ni D, Chen W, Zhang P, Song E, Wang B, Shi T, Zheng T, Zhang X.
    Urol Oncol; 2014 Jan 15; 32(1):46.e9-17. PubMed ID: 24094887
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma.
    Heinzelmann J, Henning B, Sanjmyatav J, Posorski N, Steiner T, Wunderlich H, Gajda MR, Junker K.
    World J Urol; 2011 Jun 15; 29(3):367-73. PubMed ID: 21229250
    [Abstract] [Full Text] [Related]

  • 7. 4-miRNA Score Predicts the Individual Metastatic Risk of Renal Cell Carcinoma Patients.
    Heinzelmann J, Arndt M, Pleyers R, Fehlmann T, Hoelters S, Zeuschner P, Vogt A, Pryalukhin A, Schaeffeler E, Bohle RM, Gajda M, Janssen M, Stoeckle M, Junker K.
    Ann Surg Oncol; 2019 Oct 15; 26(11):3765-3773. PubMed ID: 31270716
    [Abstract] [Full Text] [Related]

  • 8. Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma.
    Liep J, Kilic E, Meyer HA, Busch J, Jung K, Rabien A.
    PLoS One; 2016 Oct 15; 11(6):e0157801. PubMed ID: 27336447
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-217, down-regulated in clear cell renal cell carcinoma and associated with lower survival, suppresses cell proliferation and migration.
    Li H, Zhao J, Zhang JW, Huang QY, Huang JZ, Chi LS, Tang HJ, Liu GQ, Zhu DJ, Ma WM.
    Neoplasma; 2013 Oct 15; 60(5):511-5. PubMed ID: 23790169
    [Abstract] [Full Text] [Related]

  • 10. Expression of miR-27a-3p is an independent predictive factor for recurrence in clear cell renal cell carcinoma.
    Nakata W, Uemura M, Sato M, Fujita K, Jingushi K, Ueda Y, Kitae K, Tsujikawa K, Nonomura N.
    Oncotarget; 2015 Aug 28; 6(25):21645-54. PubMed ID: 26046464
    [Abstract] [Full Text] [Related]

  • 11. Down-regulation of miR-497 is associated with poor prognosis in renal cancer.
    Zhao X, Zhao Z, Xu W, Hou J, Du X.
    Int J Clin Exp Pathol; 2015 Aug 28; 8(1):758-64. PubMed ID: 25755771
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
    Yamasaki T, Seki N, Yoshino H, Itesako T, Hidaka H, Yamada Y, Tatarano S, Yonezawa T, Kinoshita T, Nakagawa M, Enokida H.
    J Urol; 2013 Sep 28; 190(3):1059-68. PubMed ID: 23454155
    [Abstract] [Full Text] [Related]

  • 13. PLAGL1 (ZAC1/LOT1) Expression in Clear Cell Renal Cell Carcinoma: Correlations with Disease Progression and Unfavorable Prognosis.
    Godlewski J, Krazinski BE, Kowalczyk AE, Kiewisz J, Kiezun J, Kwiatkowski P, Sliwinska-Jewsiewicka A, Maslowski Z, Kmiec Z.
    Anticancer Res; 2016 Feb 28; 36(2):617-24. PubMed ID: 26851016
    [Abstract] [Full Text] [Related]

  • 14. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
    Lyu X, Li H, Ma X, Li X, Gao Y, Ni D, Shen D, Gu L, Wang B, Zhang Y, Zhang X.
    Cell Biochem Biophys; 2015 Jan 28; 71(1):279-90. PubMed ID: 25120023
    [Abstract] [Full Text] [Related]

  • 15. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.
    Kosari F, Parker AS, Kube DM, Lohse CM, Leibovich BC, Blute ML, Cheville JC, Vasmatzis G.
    Clin Cancer Res; 2005 Jul 15; 11(14):5128-39. PubMed ID: 16033827
    [Abstract] [Full Text] [Related]

  • 16. Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.
    Yang Z, Yuan Z, Fan Y, Deng X, Zheng Q.
    Mol Med Rep; 2013 Nov 15; 8(5):1353-8. PubMed ID: 24064622
    [Abstract] [Full Text] [Related]

  • 17. miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression.
    Xie J, Chen M, Zhou J, Mo MS, Zhu LH, Liu YP, Gui QJ, Zhang L, Li GQ.
    Oncol Rep; 2014 Apr 15; 31(4):1715-22. PubMed ID: 24573489
    [Abstract] [Full Text] [Related]

  • 18. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B, Li J, Sun M, Sun L, Zhang X.
    IUBMB Life; 2014 May 15; 66(5):371-7. PubMed ID: 24846313
    [Abstract] [Full Text] [Related]

  • 19. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma.
    Ma X, Gu L, Li H, Gao Y, Li X, Shen D, Gong H, Li S, Niu S, Zhang Y, Fan Y, Huang Q, Lyu X, Zhang X.
    J Transl Med; 2015 Feb 12; 13():56. PubMed ID: 25740019
    [Abstract] [Full Text] [Related]

  • 20. miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma.
    Khella HW, Bakhet M, Allo G, Jewett MA, Girgis AH, Latif A, Girgis H, Von Both I, Bjarnason GA, Yousef GM.
    Carcinogenesis; 2013 Oct 12; 34(10):2231-9. PubMed ID: 23715501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 65.